Changes in Beneficial Ownership · 4
Recursion Pharmaceuticals, Inc.
RXRXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1793830355.xml
Filing details
- Report period
- 2026-11-02
- Issuer
- RECURSION PHARMACEUTICALS, INC.
- Issuer CIK
- 0001601830
- Trading symbol
- RXRX
Reporting owner 1
- Name
- Hassan Fred
- Reporting owner CIK
- 0001110744
- Relationship
- Director
- Address
- 41 S. RIO GRANDE ST., SALT LAKE CITY, UT, 84101
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-11-02 | A · Form 4 | 156,658 | A[F1] | 0 | 156,658 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.↩ 1
Signature 1
- Signed
- /s/ Kyle Nelson, attorney-in-fact
- Date
- 2026-11-02
Recent company filings
- 3 filingNov 4, 2026
- 10-Q filingNov 2, 2026
- Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureNov 2, 2026
- 424B5 filingOct 15, 2026
- Entry into a Material Definitive Agreement · Results of Operations and Financial Condition · Regulation FD Disclosure · Other EventsOct 15, 2026